Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two types of calmodulin antagonists: a structurally related interaction.

M Inagaki, H Hidaka

    Pharmacology
    |January 1, 1984
    PubMed
    Summary

    Calmodulin (CaM) antagonists show varied interactions with CaM, suggesting two distinct types. Some inhibit Ca2+-CaM-dependent phosphodiesterase (PDE), while others do not, indicating different binding mechanisms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes.

    The Journal of experimental medicine·1995
    Same author

    Elucidation of the protein kinase C-dependent apoptosis pathway in distinct subsets of T lymphocytes in MRL-lpr/lpr mice.

    European journal of immunology·1995
    Same author

    Purification and characterization of a novel protein activator of Ca2+/calmodulin-dependent protein kinase I.

    Biochemical and biophysical research communications·1995
    Same author

    Effect of KN-62, Ca2+/calmodulin-dependent protein kinase II inhibitor, on adriamycin resistance of human ovarian cancer cells.

    Biochemical and biophysical research communications·1995
    Same author

    The regulatory region of calcium/calmodulin-dependent protein kinase I contains closely associated autoinhibitory and calmodulin-binding domains.

    The Journal of biological chemistry·1995
    Same author

    Prophylaxis of genetically determined diabetes by diazoxide: a study in a rat model of naturally occurring obese diabetes.

    The Journal of pharmacology and experimental therapeutics·1995

    Area of Science:

    • Biochemistry
    • Molecular Biology
    • Pharmacology

    Background:

    • Calmodulin (CaM) is a crucial calcium-binding protein involved in numerous cellular processes.
    • CaM antagonists are used to study CaM function and have therapeutic potential.

    Purpose of the Study:

    • To investigate the distinct mechanisms of action of various CaM antagonists.
    • To differentiate between CaM antagonists based on their interaction with CaM and downstream enzyme activity.

    Main Methods:

    • Binding assays using [3H]-W-7 to measure displacement from CaM.
    • Fluorescence spectroscopy with n-phenyl-1-naphthylamine (NPN) to assess CaM complex formation.
    • 1H-nuclear magnetic resonance (NMR) to analyze structural changes in CaM.

    Main Results:

    • CaM antagonists like W-7 and trifluoperazine displaced [3H]-W-7 from CaM and inhibited Ca2+-CaM-dependent phosphodiesterase (PDE).
    • Antagonists such as prenylamine and butaclamol did not correlate PDE inhibition with [3H]-W-7 displacement and enhanced NPN fluorescence.
    • 1H-NMR revealed more pronounced spectral changes in CaM induced by prenylamine compared to W-7.

    Conclusions:

    • Findings suggest the existence of at least two distinct classes of CaM antagonists.
    • These classes may be differentiated by their binding affinity and impact on CaM's interaction with target enzymes.
    • Common molecular structures within each group of antagonists are suggested.

    Related Experiment Videos